Anti Peptic Ulcer Drugs Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032
- Report ID: ME_0063959
- Format: Electronic (PDF)
- Publish Type:
- Number of Pages: 250
Market Snapshot
CAGR:5.77
Source: Market Expertz
| Study Period | 2019-2032 |
| Base Year | 2023 |
| Forcast Year | 2023-2032 |
| CAGR | 5.77 |
Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries
Download Sample PdfReport Overview
In 2018, the global Anti Peptic Ulcer Drugs market size was million US$ and it is expected to reach million US$ by the end of 2026, with a CAGR of during 2019-2026.This report focuses on the global Anti Peptic Ulcer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti Peptic Ulcer Drugs development in United States, Europe and China.
The key players covered in this study
Eisai
Daewoong Pharmaceutical
Takeda Pharmaceutical
HeliCure
AstraZeneca
Ore Pharmaceuticals
Sihuan Pharmaceutical
GlaxoSmithKline
Pfizer
Abbott Laboratories
Yuhan Corporation
Cadila Healthcare
Boehringer Ingelheim
Market segment by Type, the product can be split into
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Antibiotics
Ulcer Protective Drugs
Market segment by Application, split into
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Anti Peptic Ulcer Drugs status, future forecast, growth opportunity, key market and key players.
To present the Anti Peptic Ulcer Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Anti Peptic Ulcer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anti Peptic Ulcer Drugs Market Size Growth Rate by Type (2014-2026)
1.4.2 Proton Pump Inhibitors (PPIs)
1.4.3 Potassium-Competitive Acid Blockers (P-CAB)
1.4.4 Antacids
1.4.5 H2 Antagonists
1.4.6 Antibiotics
1.4.7 Ulcer Protective Drugs
1.5 Market by Application
1.5.1 Global Anti Peptic Ulcer Drugs Market Share by Application (2014-2026)
1.5.2 Gastritis
1.5.3 Gastric Ulcers
1.5.4 Duodenal Ulcers
1.5.5 Gastroesophageal Reflux Disease (GERD)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Anti Peptic Ulcer Drugs Market Size
2.2 Anti Peptic Ulcer Drugs Growth Trends by Regions
2.2.1 Anti Peptic Ulcer Drugs Market Size by Regions (2014-2026)
2.2.2 Anti Peptic Ulcer Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Anti Peptic Ulcer Drugs Market Size by Manufacturers
3.1.1 Global Anti Peptic Ulcer Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Anti Peptic Ulcer Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Anti Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anti Peptic Ulcer Drugs Key Players Head office and Area Served
3.3 Key Players Anti Peptic Ulcer Drugs Product/Solution/Service
3.4 Date of Enter into Anti Peptic Ulcer Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Anti Peptic Ulcer Drugs Market Size by Type (2014-2019)
4.2 Global Anti Peptic Ulcer Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Anti Peptic Ulcer Drugs Market Size (2014-2019)
5.2 Anti Peptic Ulcer Drugs Key Players in United States
5.3 United States Anti Peptic Ulcer Drugs Market Size by Type
5.4 United States Anti Peptic Ulcer Drugs Market Size by Application
6 Europe
6.1 Europe Anti Peptic Ulcer Drugs Market Size (2014-2019)
6.2 Anti Peptic Ulcer Drugs Key Players in Europe
6.3 Europe Anti Peptic Ulcer Drugs Market Size by Type
6.4 Europe Anti Peptic Ulcer Drugs Market Size by Application
7 China
7.1 China Anti Peptic Ulcer Drugs Market Size (2014-2019)
7.2 Anti Peptic Ulcer Drugs Key Players in China
7.3 China Anti Peptic Ulcer Drugs Market Size by Type
7.4 China Anti Peptic Ulcer Drugs Market Size by Application
8 Japan
8.1 Japan Anti Peptic Ulcer Drugs Market Size (2014-2019)
8.2 Anti Peptic Ulcer Drugs Key Players in Japan
8.3 Japan Anti Peptic Ulcer Drugs Market Size by Type
8.4 Japan Anti Peptic Ulcer Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Anti Peptic Ulcer Drugs Market Size (2014-2019)
9.2 Anti Peptic Ulcer Drugs Key Players in Southeast Asia
9.3 Southeast Asia Anti Peptic Ulcer Drugs Market Size by Type
9.4 Southeast Asia Anti Peptic Ulcer Drugs Market Size by Application
10 India
10.1 India Anti Peptic Ulcer Drugs Market Size (2014-2019)
10.2 Anti Peptic Ulcer Drugs Key Players in India
10.3 India Anti Peptic Ulcer Drugs Market Size by Type
10.4 India Anti Peptic Ulcer Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Anti Peptic Ulcer Drugs Market Size (2014-2019)
11.2 Anti Peptic Ulcer Drugs Key Players in Central & South America
11.3 Central & South America Anti Peptic Ulcer Drugs Market Size by Type
11.4 Central & South America Anti Peptic Ulcer Drugs Market Size by Application
12 International Players Profiles
12.1 Eisai
12.1.1 Eisai Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anti Peptic Ulcer Drugs Introduction
12.1.4 Eisai Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.1.5 Eisai Recent Development
12.2 Daewoong Pharmaceutical
12.2.1 Daewoong Pharmaceutical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anti Peptic Ulcer Drugs Introduction
12.2.4 Daewoong Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.2.5 Daewoong Pharmaceutical Recent Development
12.3 Takeda Pharmaceutical
12.3.1 Takeda Pharmaceutical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anti Peptic Ulcer Drugs Introduction
12.3.4 Takeda Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.3.5 Takeda Pharmaceutical Recent Development
12.4 HeliCure
12.4.1 HeliCure Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anti Peptic Ulcer Drugs Introduction
12.4.4 HeliCure Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.4.5 HeliCure Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anti Peptic Ulcer Drugs Introduction
12.5.4 AstraZeneca Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Ore Pharmaceuticals
12.6.1 Ore Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Anti Peptic Ulcer Drugs Introduction
12.6.4 Ore Pharmaceuticals Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.6.5 Ore Pharmaceuticals Recent Development
12.7 Sihuan Pharmaceutical
12.7.1 Sihuan Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Anti Peptic Ulcer Drugs Introduction
12.7.4 Sihuan Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.7.5 Sihuan Pharmaceutical Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Details
12.8.2 Company Description and Business Overview
12.8.3 Anti Peptic Ulcer Drugs Introduction
12.8.4 GlaxoSmithKline Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.8.5 GlaxoSmithKline Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Anti Peptic Ulcer Drugs Introduction
12.9.4 Pfizer Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 Abbott Laboratories
12.10.1 Abbott Laboratories Company Details
12.10.2 Company Description and Business Overview
12.10.3 Anti Peptic Ulcer Drugs Introduction
12.10.4 Abbott Laboratories Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.10.5 Abbott Laboratories Recent Development
12.11 Yuhan Corporation
12.12 Cadila Healthcare
12.13 Boehringer Ingelheim
13 Market Forecast 2019-2026
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2026)
13.10 Market Size Forecast by Application (2019-2026)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Anti Peptic Ulcer Drugs Key Market Segments
Table Key Players Anti Peptic Ulcer Drugs Covered
Table Global Anti Peptic Ulcer Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Anti Peptic Ulcer Drugs Market Size Market Share by Type 2014-2025
Figure Proton Pump Inhibitors (PPIs) Figures
Table Key Players of Proton Pump Inhibitors (PPIs)
Figure Potassium-Competitive Acid Blockers (P-CAB) Figures
Table Key Players of Potassium-Competitive Acid Blockers (P-CAB)
Figure Antacids Figures
Table Key Players of Antacids
Figure H2 Antagonists Figures
Table Key Players of H2 Antagonists
Figure Antibiotics Figures
Table Key Players of Antibiotics
Figure Ulcer Protective Drugs Figures
Table Key Players of Ulcer Protective Drugs
Table Global Anti Peptic Ulcer Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Gastritis Case Studies
Figure Gastric Ulcers Case Studies
Figure Duodenal Ulcers Case Studies
Figure Gastroesophageal Reflux Disease (GERD) Case Studies
Figure Anti Peptic Ulcer Drugs Report Years Considered
Table Global Anti Peptic Ulcer Drugs Market Size 2014-2025 (Million US$)
Figure Global Anti Peptic Ulcer Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Share by Regions 2014-2019
Figure Global Anti Peptic Ulcer Drugs Market Share by Regions 2014-2019
Figure Global Anti Peptic Ulcer Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Anti Peptic Ulcer Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Share by Manufacturers (2014-2019)
Figure Global Anti Peptic Ulcer Drugs Market Share by Manufacturers in 2018
Table Global Anti Peptic Ulcer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Anti Peptic Ulcer Drugs Product/Solution/Service
Table Date of Enter into Anti Peptic Ulcer Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Size Share by Type (2014-2019)
Figure Global Anti Peptic Ulcer Drugs Market Size Market Share by Type (2014-2019)
Table Global Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Size Share by Application (2014-2019)
Figure Global Anti Peptic Ulcer Drugs Market Size Market Share by Application (2014-2019)
Figure Global Anti Peptic Ulcer Drugs Revenue Market Share by Application in 2018
Figure United States Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table United States Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table United States Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure Europe Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table Europe Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table Europe Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure China Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table China Anti Peptic Ulcer Drugs Market Size by Type (2014-20189) (Million US$)
Table China Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table China Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table China Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure Japan Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table Japan Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table Japan Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table Southeast Asia Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table Southeast Asia Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure India Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table India Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table India Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table India Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table India Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure Central & South America Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table Central & South America Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table Central & South America Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Table Eisai Company Details
Table Eisai Revenue in Anti Peptic Ulcer Drugs Business (2014-2019) (Million US$)
Figure Eisai Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Eisai Recent Development
Table Daewoong Pharmaceutical Company Details
Table Daewoong Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Daewoong Pharmaceutical Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Daewoong Pharmaceutical Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table HeliCure Company Details
Table HeliCure Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure HeliCure Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table HeliCure Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Ore Pharmaceuticals Company Details
Table Ore Pharmaceuticals Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Ore Pharmaceuticals Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Ore Pharmaceuticals Recent Development
Table Sihuan Pharmaceutical Company Details
Table Sihuan Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Sihuan Pharmaceutical Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Sihuan Pharmaceutical Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Yuhan Corporation Company Details
Table Cadila Healthcare Company Details
Table Boehringer Ingelheim Company Details
Table Global Anti Peptic Ulcer Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Anti Peptic Ulcer Drugs Market Size Share by Regions (2019-2025)
Figure Global Anti Peptic Ulcer Drugs Market Size Share by Regions in 2025
Figure United States Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Anti Peptic Ulcer Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Anti Peptic Ulcer Drugs Market Size by Product (2019-2025)
Figure Global Anti Peptic Ulcer Drugs Market Size by Product in 2025
Table Global Anti Peptic Ulcer Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Anti Peptic Ulcer Drugs Market Size by Application (2019-2025)
Figure Global Anti Peptic Ulcer Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anti Peptic Ulcer Drugs Market Size Growth Rate by Type (2014-2026)
1.4.2 Proton Pump Inhibitors (PPIs)
1.4.3 Potassium-Competitive Acid Blockers (P-CAB)
1.4.4 Antacids
1.4.5 H2 Antagonists
1.4.6 Antibiotics
1.4.7 Ulcer Protective Drugs
1.5 Market by Application
1.5.1 Global Anti Peptic Ulcer Drugs Market Share by Application (2014-2026)
1.5.2 Gastritis
1.5.3 Gastric Ulcers
1.5.4 Duodenal Ulcers
1.5.5 Gastroesophageal Reflux Disease (GERD)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Anti Peptic Ulcer Drugs Market Size
2.2 Anti Peptic Ulcer Drugs Growth Trends by Regions
2.2.1 Anti Peptic Ulcer Drugs Market Size by Regions (2014-2026)
2.2.2 Anti Peptic Ulcer Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Anti Peptic Ulcer Drugs Market Size by Manufacturers
3.1.1 Global Anti Peptic Ulcer Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Anti Peptic Ulcer Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Anti Peptic Ulcer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anti Peptic Ulcer Drugs Key Players Head office and Area Served
3.3 Key Players Anti Peptic Ulcer Drugs Product/Solution/Service
3.4 Date of Enter into Anti Peptic Ulcer Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Anti Peptic Ulcer Drugs Market Size by Type (2014-2019)
4.2 Global Anti Peptic Ulcer Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Anti Peptic Ulcer Drugs Market Size (2014-2019)
5.2 Anti Peptic Ulcer Drugs Key Players in United States
5.3 United States Anti Peptic Ulcer Drugs Market Size by Type
5.4 United States Anti Peptic Ulcer Drugs Market Size by Application
6 Europe
6.1 Europe Anti Peptic Ulcer Drugs Market Size (2014-2019)
6.2 Anti Peptic Ulcer Drugs Key Players in Europe
6.3 Europe Anti Peptic Ulcer Drugs Market Size by Type
6.4 Europe Anti Peptic Ulcer Drugs Market Size by Application
7 China
7.1 China Anti Peptic Ulcer Drugs Market Size (2014-2019)
7.2 Anti Peptic Ulcer Drugs Key Players in China
7.3 China Anti Peptic Ulcer Drugs Market Size by Type
7.4 China Anti Peptic Ulcer Drugs Market Size by Application
8 Japan
8.1 Japan Anti Peptic Ulcer Drugs Market Size (2014-2019)
8.2 Anti Peptic Ulcer Drugs Key Players in Japan
8.3 Japan Anti Peptic Ulcer Drugs Market Size by Type
8.4 Japan Anti Peptic Ulcer Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Anti Peptic Ulcer Drugs Market Size (2014-2019)
9.2 Anti Peptic Ulcer Drugs Key Players in Southeast Asia
9.3 Southeast Asia Anti Peptic Ulcer Drugs Market Size by Type
9.4 Southeast Asia Anti Peptic Ulcer Drugs Market Size by Application
10 India
10.1 India Anti Peptic Ulcer Drugs Market Size (2014-2019)
10.2 Anti Peptic Ulcer Drugs Key Players in India
10.3 India Anti Peptic Ulcer Drugs Market Size by Type
10.4 India Anti Peptic Ulcer Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Anti Peptic Ulcer Drugs Market Size (2014-2019)
11.2 Anti Peptic Ulcer Drugs Key Players in Central & South America
11.3 Central & South America Anti Peptic Ulcer Drugs Market Size by Type
11.4 Central & South America Anti Peptic Ulcer Drugs Market Size by Application
12 International Players Profiles
12.1 Eisai
12.1.1 Eisai Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anti Peptic Ulcer Drugs Introduction
12.1.4 Eisai Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.1.5 Eisai Recent Development
12.2 Daewoong Pharmaceutical
12.2.1 Daewoong Pharmaceutical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anti Peptic Ulcer Drugs Introduction
12.2.4 Daewoong Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.2.5 Daewoong Pharmaceutical Recent Development
12.3 Takeda Pharmaceutical
12.3.1 Takeda Pharmaceutical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anti Peptic Ulcer Drugs Introduction
12.3.4 Takeda Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.3.5 Takeda Pharmaceutical Recent Development
12.4 HeliCure
12.4.1 HeliCure Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anti Peptic Ulcer Drugs Introduction
12.4.4 HeliCure Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.4.5 HeliCure Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anti Peptic Ulcer Drugs Introduction
12.5.4 AstraZeneca Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Ore Pharmaceuticals
12.6.1 Ore Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Anti Peptic Ulcer Drugs Introduction
12.6.4 Ore Pharmaceuticals Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.6.5 Ore Pharmaceuticals Recent Development
12.7 Sihuan Pharmaceutical
12.7.1 Sihuan Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Anti Peptic Ulcer Drugs Introduction
12.7.4 Sihuan Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.7.5 Sihuan Pharmaceutical Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Details
12.8.2 Company Description and Business Overview
12.8.3 Anti Peptic Ulcer Drugs Introduction
12.8.4 GlaxoSmithKline Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.8.5 GlaxoSmithKline Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Anti Peptic Ulcer Drugs Introduction
12.9.4 Pfizer Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.9.5 Pfizer Recent Development
12.10 Abbott Laboratories
12.10.1 Abbott Laboratories Company Details
12.10.2 Company Description and Business Overview
12.10.3 Anti Peptic Ulcer Drugs Introduction
12.10.4 Abbott Laboratories Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)
12.10.5 Abbott Laboratories Recent Development
12.11 Yuhan Corporation
12.12 Cadila Healthcare
12.13 Boehringer Ingelheim
13 Market Forecast 2019-2026
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2026)
13.10 Market Size Forecast by Application (2019-2026)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Anti Peptic Ulcer Drugs Key Market Segments
Table Key Players Anti Peptic Ulcer Drugs Covered
Table Global Anti Peptic Ulcer Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Anti Peptic Ulcer Drugs Market Size Market Share by Type 2014-2025
Figure Proton Pump Inhibitors (PPIs) Figures
Table Key Players of Proton Pump Inhibitors (PPIs)
Figure Potassium-Competitive Acid Blockers (P-CAB) Figures
Table Key Players of Potassium-Competitive Acid Blockers (P-CAB)
Figure Antacids Figures
Table Key Players of Antacids
Figure H2 Antagonists Figures
Table Key Players of H2 Antagonists
Figure Antibiotics Figures
Table Key Players of Antibiotics
Figure Ulcer Protective Drugs Figures
Table Key Players of Ulcer Protective Drugs
Table Global Anti Peptic Ulcer Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Gastritis Case Studies
Figure Gastric Ulcers Case Studies
Figure Duodenal Ulcers Case Studies
Figure Gastroesophageal Reflux Disease (GERD) Case Studies
Figure Anti Peptic Ulcer Drugs Report Years Considered
Table Global Anti Peptic Ulcer Drugs Market Size 2014-2025 (Million US$)
Figure Global Anti Peptic Ulcer Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Share by Regions 2014-2019
Figure Global Anti Peptic Ulcer Drugs Market Share by Regions 2014-2019
Figure Global Anti Peptic Ulcer Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Anti Peptic Ulcer Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Share by Manufacturers (2014-2019)
Figure Global Anti Peptic Ulcer Drugs Market Share by Manufacturers in 2018
Table Global Anti Peptic Ulcer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Anti Peptic Ulcer Drugs Product/Solution/Service
Table Date of Enter into Anti Peptic Ulcer Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Size Share by Type (2014-2019)
Figure Global Anti Peptic Ulcer Drugs Market Size Market Share by Type (2014-2019)
Table Global Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Anti Peptic Ulcer Drugs Market Size Share by Application (2014-2019)
Figure Global Anti Peptic Ulcer Drugs Market Size Market Share by Application (2014-2019)
Figure Global Anti Peptic Ulcer Drugs Revenue Market Share by Application in 2018
Figure United States Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table United States Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table United States Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure Europe Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table Europe Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table Europe Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure China Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table China Anti Peptic Ulcer Drugs Market Size by Type (2014-20189) (Million US$)
Table China Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table China Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table China Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure Japan Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table Japan Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table Japan Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table Southeast Asia Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table Southeast Asia Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure India Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table India Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table India Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table India Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table India Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Figure Central & South America Anti Peptic Ulcer Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Anti Peptic Ulcer Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Anti Peptic Ulcer Drugs Market Share (2018-2019)
Table Central & South America Anti Peptic Ulcer Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Anti Peptic Ulcer Drugs Market Share by Type (2014-2019)
Table Central & South America Anti Peptic Ulcer Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Anti Peptic Ulcer Drugs Market Share by Application (2014-2019)
Table Eisai Company Details
Table Eisai Revenue in Anti Peptic Ulcer Drugs Business (2014-2019) (Million US$)
Figure Eisai Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Eisai Recent Development
Table Daewoong Pharmaceutical Company Details
Table Daewoong Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Daewoong Pharmaceutical Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Daewoong Pharmaceutical Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table HeliCure Company Details
Table HeliCure Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure HeliCure Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table HeliCure Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Ore Pharmaceuticals Company Details
Table Ore Pharmaceuticals Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Ore Pharmaceuticals Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Ore Pharmaceuticals Recent Development
Table Sihuan Pharmaceutical Company Details
Table Sihuan Pharmaceutical Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Sihuan Pharmaceutical Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Sihuan Pharmaceutical Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Anti Peptic Ulcer Drugs Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Anti Peptic Ulcer Drugs Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Yuhan Corporation Company Details
Table Cadila Healthcare Company Details
Table Boehringer Ingelheim Company Details
Table Global Anti Peptic Ulcer Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Anti Peptic Ulcer Drugs Market Size Share by Regions (2019-2025)
Figure Global Anti Peptic Ulcer Drugs Market Size Share by Regions in 2025
Figure United States Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Anti Peptic Ulcer Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Anti Peptic Ulcer Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Anti Peptic Ulcer Drugs Market Size by Product (2019-2025)
Figure Global Anti Peptic Ulcer Drugs Market Size by Product in 2025
Table Global Anti Peptic Ulcer Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Anti Peptic Ulcer Drugs Market Size by Application (2019-2025)
Figure Global Anti Peptic Ulcer Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
RESEARCH METHODOLOGY
A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.
Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.
Now let’s take a closer look at the research methods here.
Secondary Research Model
Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.
Primary Insights
Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.
However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.
Market Estimation
The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.
Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.
Final Presentation
The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Personalized Business Report Tailored to Your Requirements
- Our expert analysts collaborate directly with you to comprehend your specific needs.
- Get data on regions, segments, competitors, and vendors of your choice.
- Information is presented in alignment with your exact preferences and formatting.
Free Sample Report
"Find new revenue generation opportunities"